Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy (vol 59, pg 83, 2003)

被引：0
|
作者：
Onozato, ML [1 ]
Tojo, A [1 ]
Goto, A [1 ]
Fujita, T [1 ]
机构：
[1] Univ Tokyo, Dept Internal Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2003年 / 60卷 / 03期
关键词：
D O I：
10.1016/S0168-8227(03)00086-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：217 / 217
页数：1
相关论文
共 50 条
  • [21] Organic field-effect transistors by a wet-transferring method (vol 83, pg 1243, 2003)
    Noh, YY
    Kim, JJ
    Yase, K
    APPLIED PHYSICS LETTERS, 2003, 83 (12) : 2490 - 2490
  • [22] THE EFFECT OF TREATMENT WITH PREDNISOLONE OR CYCLOPHOSPHAMIDE WARFARIN DIPYRIDAMOLE COMBINATION ON THE OUTCOME OF PATIENTS WITH MEMBRANOUS NEPHROPATHY
    SHEARMAN, JD
    YIN, ZG
    AARONS, I
    SMITH, PS
    WOODROFFE, AJ
    CLARKSON, AR
    CLINICAL NEPHROLOGY, 1988, 30 (06) : 320 - 329
  • [23] Corrigendum to "Work and disproportionation for aqueous plutonium" (vol 59, pg 217, 2003)
    Silver, GL
    APPLIED RADIATION AND ISOTOPES, 2004, 60 (05) : 783 - 783
  • [24] Transposition of external genitalia and associated malformations (vol 12, pg 59, 2003)
    Meguid, NA
    Temtamy, SA
    Mazen, I
    CLINICAL DYSMORPHOLOGY, 2003, 12 (02) : 152 - 152
  • [25] Therapeutic effect and mechanism of combination therapy with ursolic acid and insulin on diabetic nephropathy in a type I diabetic rat model
    Liu, Yang
    Zheng, Jin-Yan
    Wei, Zhi-Tao
    Liu, Shu-Kun
    Sun, Ji-Lei
    Mao, Yin-Hui
    Xu, Yong-De
    Yang, Yong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] Captopril and Combination Therapy of Captopril and Pentoxifylline in Reducing Proteinuria in Diabetic Nephropathy
    Roozbeh, Jamshid
    Banihashemi, Mohammad Amin
    Ghezlou, Mohammad
    Afshariani, Raha
    Salari, Soheila
    Moini, Maryam
    Sagheb, Mohammad Mahdi
    RENAL FAILURE, 2010, 32 (02) : 172 - 178
  • [27] Diabetic nephropathy: Recent insights into the pathophysiology and the progression of diabetic nephropathy (vol 65, pg S50, 2005)
    Gross, ML
    Ritz, E
    KIDNEY INTERNATIONAL, 2005, 68 (01) : 427 - 427
  • [28] Diabetic nephropathy - where next? (vol 93, pg 643, 2000)
    Phillips, AO
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 2001, 94 (01): : 51 - 51
  • [29] Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats
    Balakumar, Pitchai
    Varatharajan, Rajavel
    Nyo, Ying Hui
    Renushia, Raja
    Raaginey, Devarajan
    Oh, Ann Nah
    Akhtar, Shaikh Sohrab
    Rupeshkumar, Mani
    Sundram, Karupiah
    Dhanaraj, Sokkalingam A.
    PHARMACOLOGICAL RESEARCH, 2014, 90 : 36 - 47
  • [30] THE EFFECT OF ANGIOTENSIN-CONVERTING-ENZYME INHIBITION ON DIABETIC NEPHROPATHY (VOL 329, PG 1456, 1993)
    LEWIS, EJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (02): : 152 - 152
12345